NCT02547844View on ClinicalTrials.gov

Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With Atripla

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

HIV-1

Interventions

DRUG

efavirenz + emtricitabina + tenofovir

DRUG

rilpivirina + emtricitabina + tenofovir

Trial Locations (1)

08035

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER